Currently Skimming:
Appendix A: Workshop Agenda
Appendix A: Workshop Agenda
Pages 129-140
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 129... ...
IOM. The objectives of the workshop series are: • The multi-disciplinary workshops span a wide spectrum of issues pertaining to the science and policy around drug-resistant tuberculosis -- from biology, epidemiology, and surveillance; to diagnosis, treatment, and infection control; to issues pertaining to the drug supply chain, laboratory capacity, and needs of vulnerable populations.
|
From page 130... ...
Krishan LaL Indian National Science Academy GaiL CasseLL, Forum Co-Chair Harvard Medical School Infectious Disease Research Institute PraKash n. Tandon Indian National Science Academy Vishwa Mohan KaToCh Indian Council of Medical Research Keynote Addresses 9:40-10:00 a.m.
|
From page 131... ...
Session Chair: Salmaan Keshavjee, Harvard Medical School § National Scale-Up of Drug-Resistant TB Diagnosis and Treatment 11:05-11:20 a.m. KuLdeeP sinGh saChdeVa RNTCP Ministry of Health and Family Welfare Overview of Drug-Resistant TB in India 11:20-11:35 a.m.
|
From page 132... ...
Session Chair: § ail Cassell, Harvard Medical School and Infectious Disease G Research Institute Overview of Findings from IOM Workshop Series 1:15-1:45 p.m. China data provided by Mingting Chen, Centers for Disease Control GaiL CasseLL Harvard Medical School Infectious Disease Research Institute Overview of Global Drug-Resistant TB Burden 1:45-1:55 p.m.
|
From page 133... ...
Session Chairs: § dward Nardell, Harvard Medical School/Partners In Health E § shok Kumar, RNTCP A Importance of Engaging the Private Sector in 2:00-2:15 p.m. MDR TB Prevention and Case-Finding PuneeT dewan WHO Drug-Resistant TB Transmission and Reactivation/ 2:15-2:30 p.m.
|
From page 134... ...
§ arman Singh, AIIMS S Treatment of Drug-Resistant TB 3:45-4:00 p.m. rohiT sarin Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases Diagnosis of Drug-Resistant TB 4:00-4:15 p.m.
|
From page 135... ...
Roundtable Discussion 5:15-5:45 p.m. Open Discussion with Workshop Participants DAY 2 SESSION V: REACHING VULNERABLE POPULATIONS AFFECTED BY DRUG-RESISTANT TB Session Objectives: § iscuss ways to address priorities of reaching and treating D drug-resistant TB patients in the large Indian population.
|
From page 136... ...
Patients with MDR TB MerCedes beCerra Harvard Medical School Drug Resistance in India's HIV-Infected Population 9:30-10:00 a.m. diGaMbar behera Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases Drug-Resistant TB in Migrant and Refugee Populations KunChoK dorjee Tibetan TB Control Programme, Department of Health, Tibetan Government in Exile Roundtable Discussion 10:00-10:30 a.m.
|
From page 137... ...
Response and How an NGO Filled the Gap anne GoLdfeLd Global Health Committee/Cambodian Health Committee Harvard Medical School 11:45 a.m. Discussion 12:15 p.m.
|
From page 138... ...
Market owen robinson Partners In Health Roundtable Discussion 2:15-2:45 p.m. Facilitator: Anne Goldfeld, Global Health Committee/Cambodian Health Committee, Harvard Medical School
|
From page 139... ...
§ ow can domestic programs and international partners work H together to create a "blueprint for action" to address the problem of drug-resistant tuberculosis? § onsider opportunities to address the problem of drug C resistant tuberculosis in India's next 5-year budget plan.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.